BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  Zafgen Announces New Weight Loss And Safety Data From Phase II Trial Of Beloranib In Hypothalamic Injury Associated Obesity At ENDO 2015

  March 9, 2015

   · 

  8 min read
• Policy

  FDA Wants AcelRx to Run Another Trial on Zalviso Drug-Device Combo

  March 9, 2015

   · 

  7 min read
• Deals

  Synaptive Medical Acquires ClearCanvas To Help Redefine The Standard Landscape Of Medical Imaging

  March 9, 2015

   · 

  2 min read
• FDA

  Astellas Pharma Inc. Receives FDA Approval for CRESEMBA (isavuconazonium sulfate) For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis

  March 9, 2015

   · 

  8 min read
• Drug Development

  Novo Nordisk A/S Release: New Data In Adults With Obesity Or Who Are Overweight With Comorbidities Losing At Least 5% Body Weight With Saxenda (liraglutide [rDNA origin] injection) Showed Improvement In Blood Glucose, CV Risk Factors And Quality Of Life O

  March 9, 2015

   · 

  13 min read
• St. Jude Children’s Research Hospital Release: Researchers Map “Genomic Landscape” Of Childhood Adrenocortical Tumors For The First Time

  March 9, 2015

   · 

  5 min read
• Business

  EMD Serono And Opexa Therapeutics Amend Agreement To Support Ongoing Development Of Tcelna (Imilecleucel-T) For Multiple Sclerosis

  March 9, 2015

   · 

  3 min read
• BioMidwest

  Great Basin Scientific, Inc. Announces Final Closing Of Public Offering

  March 9, 2015

   · 

  3 min read
• Pharm Country

  NanoViricides, Inc. Issued Registered Shares As Interest To Certain Debenture Holders

  March 9, 2015

   · 

  3 min read
• BioCapital

  RegeneRx Biopharmaceuticals, Inc. Joint Venture Partner Receives $7.28 Million USD From Korean Government And Venture Fund For U.S. Development Of RGN-259/GBT-201

  March 9, 2015

   · 

  5 min read